| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Ives Ultra AI Opportunities Inc.
13D
IVAI · 90386L108
|
9.4% |
10/30/2026
Event 10/31/2026
|
|||
| YA II PN, Ltd. | 9.4% | ||||
| YA Global Investments II (U.S.), LP | 9.4% | ||||
| Yorkville Advisors Global, LP | 9.4% | ||||
| Yorkville Advisors Global II, LLC | 9.4% | ||||
| Yaii GP, LP | 9.4% | ||||
| Yaii GP II, LLC | 9.4% | ||||
| Mark Angelo | 9.4% | ||||
|
Beneficient
13G/A
Amendment 2
BENF · 08178Q101
|
0% |
10/5/2026
Event 9/30/2026
|
|||
| YA II PN, Ltd. | 0% | ||||
| YA Global Investments II (U.S.), LP | 0% | ||||
| Yorkville Advisors Global, LP | 0% | ||||
| Yorkville Advisors Global II, LLC | 0% | ||||
| Yaii GP, LP | 0% | ||||
| Yaii GP II, LLC | 0% | ||||
| Mark Angelo | 0% | ||||
|
Optimi Health Corp.
13G/A
Amendment 1
OPTH · 68405H308
|
3.0% |
10/5/2026
Event 9/30/2026
|
|||
| YA II PN, Ltd. | 3.0% | ||||
| YA Global Investments II (U.S.), LP | 3.0% | ||||
| Yorkville Advisors Global, LP | 3.0% | ||||
| Yorkville Advisors Global II, LLC | 3.0% | ||||
| Yaii GP, LP | 3.0% | ||||
| Yaii GP II, LLC | 3.0% | ||||
| Mark Angelo | 3.0% | ||||
|
PRF Technologies Ltd.
13G/A
Amendment 1
PRFX · M77798201
|
10.0% |
6/22/2026
Event 6/18/2026
|
|||
| YA II PN, Ltd. | 10.0% | ||||
| YA Global Investments II (U.S.), LP | 10.0% | ||||
| Yorkville Advisors Global, LP | 10.0% | ||||
| Yorkville Advisors Global II, LLC | 10.0% | ||||
| Yaii GP, LP | 9.9% | ||||
| Yaii GP II, LLC | 10.0% | ||||
| Mark Angelo | 10.0% | ||||
| SC-Sigma Global Partners, LP | 10.0% | ||||
|
Optimi Health Corp.
13G
OPTH · 68405H308
|
7.1% |
5/27/2026
Event 5/20/2026
|
|||
| YA II PN, Ltd. | 7.1% | ||||
| YA Global Investments II (U.S.), LP | 7.1% | ||||
| Yorkville Advisors Global, LP | 7.1% | ||||
| Yorkville Advisors Global II, LLC | 7.1% | ||||
| Yaii GP, LP | 7.1% | ||||
| Yaii GP II, LLC | 7.1% | ||||
| Mark Angelo | 7.1% | ||||
| SC-Sigma Global Partners, LP | 7.1% | ||||
|
PRF Technologies Ltd.
13G
PRFX · M77798201
|
10.0% |
5/12/2026
Event 5/7/2026
|
|||
| YA II PN, Ltd. | 10.0% | ||||
| YA Global Investments II (U.S.), LP | 10.0% | ||||
| Yorkville Advisors Global, LP | 10.0% | ||||
| Yorkville Advisors Global II, LLC | 10.0% | ||||
| Yaii GP, LP | 9.9% | ||||
| Yaii GP II, LLC | 10.0% | ||||
| Mark Angelo | 10.0% | ||||
| SC-Sigma Global Partners, LP | 10.0% | ||||
|
TransCode Therapeutics, Inc.
13G
RNAZ · 89357L501
|
9.9% |
4/20/2026
Event 4/15/2026
|
|||
| YA II PN, Ltd. | 9.9% | ||||
| YA Global Investments II (U.S.), LP | 9.9% | ||||
| Yorkville Advisors Global, LP | 9.9% | ||||
| Yorkville Advisors Global II, LLC | 9.9% | ||||
| Yaii GP, LP | 9.9% | ||||
| Yaii GP II, LLC | 9.9% | ||||
| Mark Angelo | 9.9% | ||||
| SC-Sigma Global Partners, LP | 9.9% | ||||
|
Xos, Inc.
13G/A
Amendment 3
XOS · 98423B108
|
0% |
4/6/2026
Event 12/31/2025
|
|||
| YA II PN, Ltd. | 0% | ||||
| YA Global Investments II (U.S.), LP | 0% | ||||
| Yorkville Advisors Global, LP | 0% | ||||
| Yorkville Advisors Global II, LLC | 0% | ||||
| Yaii GP, LP | 0% | ||||
| Yaii GP II, LLC | 0% | ||||
| Mark Angelo | 0% | ||||
| SC-Sigma Global Partners, LP | 0% | ||||
|
Indaptus Therapeutics, Inc.
13G/A
Amendment 1
INDP · 45339J105
|
0% |
4/6/2026
Event 12/31/2025
|
|||
| YA II PN, Ltd. | 0% | ||||
| YA Global Investments II (U.S.), LP | 0% | ||||
| Yorkville Advisors Global, LP | 0% | ||||
| Yorkville Advisors Global II, LLC | 0% | ||||
| Yaii GP, LP | 0% | ||||
| Yaii GP II, LLC | 0% | ||||
| Mark Angelo | 0% | ||||
| SC-Sigma Global Partners, LP | 0% | ||||
|
Strive, Inc.
13G/A
Amendment 1
ASST · 862945102
|
3.6% |
2/3/2026
Event 12/31/2025
|
|||
| YA II PN, Ltd. | 3.6% | ||||
| YA Global Investments II (U.S.), LP | 3.6% | ||||
| Yorkville Advisors Global, LP | 3.6% | ||||
| Yorkville Advisors Global II, LLC | 3.6% | ||||
| Yaii GP, LP | 3.6% | ||||
| Yaii GP II, LLC | 3.6% | ||||
| Mark Angelo | 3.6% | ||||
| SC-Sigma Global Partners, LP | 3.6% | ||||
|
Faraday Future Intelligent Electric Inc.
13G/A
Amendment 2
FFIE · 307359505
|
0% |
1/13/2026
Event 12/31/2025
|
|||
| YA II PN, Ltd. | 0% | ||||
| YA Global Investments II (U.S.), LP | 0% | ||||
| Yorkville Advisors Global, LP | 0% | ||||
| Yorkville Advisors Global II, LLC | 0% | ||||
| Yaii GP, LP | 0% | ||||
| Yaii GP II, LLC | 0% | ||||
| Mark Angelo | 0% | ||||
| SC-Sigma Global Partners, LP | 0% | ||||
|
RedHill Biopharma Ltd.
13G
RDHL · 757468301
|
9.9% |
12/23/2025
Event 12/19/2025
|
|||
| YA II PN, Ltd. | 9.9% | ||||
| YA Global Investments II (U.S.), LP | 9.9% | ||||
| Yorkville Advisors Global, LP | 9.9% | ||||
| Yorkville Advisors Global II, LLC | 9.9% | ||||
| Yaii GP, LP | 9.9% | ||||
| Yaii GP II, LLC | 9.9% | ||||
| Mark Angelo | 9.9% | ||||
| SC-Sigma Global Partners, LP | 9.9% | ||||
|
New America Acquisition I Corp.
13G/A
Amendment 1
NWAXU · 023634207
|
4.9% |
12/5/2025
Event 12/4/2025
|
|||
| YA II PN, Ltd. | 4.9% | ||||
| YA Global Investments II (U.S.), LP | 4.9% | ||||
| Yorkville Advisors Global, LP | 4.9% | ||||
| Yorkville Advisors Global II, LLC | 4.9% | ||||
| Yaii GP, LP | 4.9% | ||||
| Yaii GP II, LLC | 4.9% | ||||
| Mark Angelo | 4.9% | ||||
| SC-Sigma Global Partners, LP | 4.9% | ||||
|
New America Acquisition I Corp.
13G
NWAXU · 023634207
|
10.0% |
12/4/2025
Event 12/4/2025
|
|||
| YA II PN, Ltd. | 10.0% | ||||
| YA Global Investments II (U.S.), LP | 10.0% | ||||
| Yorkville Advisors Global, LP | 10.0% | ||||
| Yorkville Advisors Global II, LLC | 10.0% | ||||
| Yaii GP, LP | 10.0% | ||||
| Yaii GP II, LLC | 10.0% | ||||
| Mark Angelo | 10.0% | ||||
| SC-Sigma Global Partners, LP | 10.0% | ||||
|
Sequans Communications
13G/A
Amendment 1
SQNS · 817323306
|
0.7% |
10/17/2025
Event 9/30/2025
|
|||
| YA II PN, Ltd. | 0.7% | ||||
| YA Global Investments II (U.S.), LP | 0.7% | ||||
| Yorkville Advisors Global, LP | 0.7% | ||||
| Yorkville Advisors Global II, LLC | 0.7% | ||||
| Yaii GP, LP | 0.7% | ||||
| Yaii GP II, LLC | 0.7% | ||||
| Mark Angelo | 0.7% | ||||
| SC-Sigma Global Partners, LP | 0.7% | ||||
|
Prestige Wealth Inc.
13G
AURE · G7244A119
|
10.0% |
10/17/2025
Event 10/10/2025
|
|||
| YA II PN, Ltd. | 10.0% | ||||
| YA Global Investments II (U.S.), LP | 10.0% | ||||
| Yorkville Advisors Global, LP | 10.0% | ||||
| Yorkville Advisors Global II, LLC | 10.0% | ||||
| Yaii GP, LP | 10.0% | ||||
| Yaii GP II, LLC | 10.0% | ||||
| Mark Angelo | 10.0% | ||||
| SC-Sigma Global Partners, LP | 10.0% | ||||
|
Strive, Inc.
13G
ASST · 862945102
|
9.9% |
10/7/2025
Event 9/12/2025
|
|||
| YA II PN, Ltd. | 9.9% | ||||
| YA Global Investments II (U.S.), LP | 9.9% | ||||
| Yorkville Advisors Global, LP | 9.9% | ||||
| Yorkville Advisors Global II, LLC | 9.9% | ||||
| Yaii GP, LP | 9.9% | ||||
| Yaii GP II, LLC | 9.9% | ||||
| Mark Angelo | 9.9% | ||||
| SC-Sigma Global Partners, LP | 9.9% | ||||
|
Sequans Communications
13G
SQNS · 817323306
|
9.9% |
7/14/2025
Event 7/7/2025
|
|||
| YA II PN, Ltd. | 9.9% | ||||
| YA Global Investments II (U.S.), LP | 9.9% | ||||
| Yorkville Advisors Global, LP | 9.9% | ||||
| Yorkville Advisors Global II, LLC | 9.9% | ||||
| Yaii GP, LP | 9.9% | ||||
| Yaii GP II, LLC | 9.9% | ||||
| Mark Angelo | 9.9% | ||||
| SC-Sigma Global Partners, LP | 9.9% | ||||
|
Aptevo Therapeutics Inc.
13G
APVO · 03835L504
|
10.0% |
7/8/2025
Event 6/16/2025
|
|||
| YA II PN, Ltd. | 10.0% | ||||
| YA Global Investments II (U.S.), LP | 10.0% | ||||
| Yorkville Advisors Global, LP | 10.0% | ||||
| Yorkville Advisors Global II, LLC | 10.0% | ||||
| Yaii GP, LP | 10.0% | ||||
| Yaii GP II, LLC | 10.0% | ||||
| Mark Angelo | 10.0% | ||||
| SC-Sigma Global Partners, LP | 10.0% | ||||
|
Mobile-health Network Solutions
13G
MNDR · G62264117
|
10.0% |
4/1/2025
Event 3/31/2025
|
|||
| YA II PN, Ltd. | 10.0% | ||||
| YA Global Investments II (U.S.), LP | 10.0% | ||||
| Yorkville Advisors Global, LP | 10.0% | ||||
| Yorkville Advisors Global II, LLC | 10.0% | ||||
| Yaii GP, LP | 9.9% | ||||
| Yaii GP II, LLC | 10.0% | ||||
| Mark Angelo | 10.0% | ||||
| SC-Sigma Global Partners, LP | 10.0% | ||||
|
Scinai Immunotherapeutics Ltd.
13G
09073Q203
|
9.9% |
3/26/2025
Event 3/24/2025
|
|||
| YA II PN, Ltd. | 9.9% | ||||
| YA Global Investments II (U.S.), LP | 9.9% | ||||
| Yorkville Advisors Global, LP | 9.9% | ||||
| Yorkville Advisors Global II, LLC | 9.9% | ||||
| Yaii GP, LP | 9.9% | ||||
| Yaii GP II, LLC | 9.9% | ||||
| Mark Angelo | 9.9% | ||||
| SC-Sigma Global Partners, LP | 9.9% | ||||
|
Indaptus Therapeutics, Inc.
13G
INDP · 45339J105
|
10.0% |
2/18/2025
Event 2/13/2025
|
|||
| YA II PN, Ltd. | 10.0% | ||||
| YA Global Investments II (U.S.), LP | 10.0% | ||||
| Yorkville Advisors Global, LP | 10.0% | ||||
| Yorkville Advisors Global II, LLC | 10.0% | ||||
| Yaii GP, LP | 10.0% | ||||
| Yaii GP II, LLC | 10.0% | ||||
| Mark Angelo | 10.0% | ||||
| SC-Sigma Global Partners, LP | 10.0% | ||||
|
Soluna Holdings, Inc.
13G
SLNH · 583543301
|
10.0% |
2/6/2025
Event 2/5/2025
|
|||
| YA II PN, Ltd. | 10.0% | ||||
| YA Global Investments II (U.S.), LP | 10.0% | ||||
| Yorkville Advisors Global, LP | 10.0% | ||||
| Yorkville Advisors Global II, LLC | 10.0% | ||||
| Yaii GP, LP | 10.0% | ||||
| Yaii GP II, LLC | 10.0% | ||||
| Mark Angelo | 10.0% | ||||
| SC-Sigma Global Partners, LP | 10.0% | ||||
|
Voyager Acquisition Corp.
13G/A
Amendment 2
VACH · G93A7H104
|
0.2% |
1/13/2025
Event 12/31/2024
|
|||
| YA II PN, Ltd. | 0.2% | ||||
| YA Global Investments II (U.S.), LP | 0.2% | ||||
| Yorkville Advisors Global, LP | 0.2% | ||||
| Yorkville Advisors Global II, LLC | 0.2% | ||||
| Yaii GP, LP | 0.2% | ||||
| Yaii GP II, LLC | 0.2% | ||||
| Mark Angelo | 0.2% | ||||
| SC-Sigma Global Partners, LP | 0.2% | ||||
|
micromobility.com Inc.
13G/A
Amendment 2
HLBZ · 42309B204
|
0% |
1/13/2025
Event 12/31/2024
|
|||
| YA II PN, Ltd. | 0% | ||||
| YA Global Investments II (U.S.), LP | 0% | ||||
| Yorkville Advisors Global, LP | 0% | ||||
| Yorkville Advisors Global II, LLC | 0% | ||||
| Yaii GP, LP | 0% | ||||
| Yaii GP II, LLC | 0% | ||||
| Mark Angelo | 0% | ||||
| SC-Sigma Global Partners, LP | 0% | ||||
|
InMed Pharmaceuticals Inc.
13G
INM · 457637601
|
10.0% |
12/18/2024
Event 12/13/2024
|
|||
| YA II PN, Ltd. | 10.0% | ||||
| YA Global Investments II (U.S.), LP | 10.0% | ||||
| Yorkville Advisors Global, LP | 10.0% | ||||
| Yorkville Advisors Global II, LLC | 10.0% | ||||
| Ya II GP, LP | 10.0% | ||||
| Yaii GP II, LLC | 10.0% | ||||
| Mark Angelo | 10.0% | ||||
| SC-Sigma Global Partners, LP | 10.0% | ||||
|
FACT II Acquisition Corp.
13G/A
Amendment 1
FACTU · G32901111
|
0.5% |
12/3/2024
Event 11/26/2024
|
|||
| YA II PN, Ltd. | 0.5% | ||||
| YA Global Investments II (U.S.), LP | 0.5% | ||||
| Yorkville Advisors Global, LP | 0.5% | ||||
| Yorkville Advisors Global II, LLC | 0.5% | ||||
| Yaii GP, LP | 0.5% | ||||
| Yaii GP II, LLC | 0.5% | ||||
| Mark Angelo | 0.5% | ||||
| SC-Sigma Global Partners, LP | 0.5% | ||||
|
FACT II Acquisition Corp.
13G
FACTU · G32901111
|
9.4% |
11/29/2024
Event 11/26/2024
|
|||
| YA II PN, Ltd. | 9.4% | ||||
| YA Global Investments II (U.S.), LP | 9.4% | ||||
| Yorkville Advisors Global, LP | 9.4% | ||||
| Yorkville Advisors Global II, LLC | 9.4% | ||||
| Yaii GP, LP | 9.4% | ||||
| Yaii GP II, LLC | 9.4% | ||||
| Mark Angelo | 9.4% | ||||
| SC-Sigma Global Partners, LP | 9.4% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.